Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis.
Naegelin Y, Rasenack M, Andelova M, Von Felten S, Fischer-Barnicol B, Amann M, Mehling M, Kappos L, Sprenger T, Derfuss T. Naegelin Y, et al. Among authors: sprenger t. Mult Scler Relat Disord. 2018 Oct;25:14-20. doi: 10.1016/j.msard.2018.07.005. Epub 2018 Jul 6. Mult Scler Relat Disord. 2018. PMID: 30014876 Free article.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Filli L, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Sprenger T, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K. Filli L, et al. Among authors: sprenger t. Mult Scler. 2012 Nov;18(11):1577-84. doi: 10.1177/1352458512442756. Epub 2012 Apr 11. Mult Scler. 2012. PMID: 22495945
Teriflunomide for oral therapy in multiple sclerosis.
Papadopoulou A, Kappos L, Sprenger T. Papadopoulou A, et al. Among authors: sprenger t. Expert Rev Clin Pharmacol. 2012 Nov;5(6):617-28. doi: 10.1586/ecp.12.56. Expert Rev Clin Pharmacol. 2012. PMID: 23234322
The typical duration of migraine aura: a systematic review.
Viana M, Sprenger T, Andelova M, Goadsby PJ. Viana M, et al. Among authors: sprenger t. Cephalalgia. 2013 May;33(7):483-90. doi: 10.1177/0333102413479834. Epub 2013 Mar 8. Cephalalgia. 2013. PMID: 23475294 Review.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T. Ricklin ME, et al. Among authors: sprenger t. Neurology. 2013 Jul 9;81(2):174-81. doi: 10.1212/WNL.0b013e31829a3311. Epub 2013 May 22. Neurology. 2013. PMID: 23700335
257 results